The ethics of nanobiotechnology: A call for global regulation

FHS
July 13, 2023
2:56 pm

Prosthetics moved by thoughts. Targeted treatments for aggressive brain cancer. Soldiers with enhanced vision or bionic ears.

‘An incredible undertaking’: 5 takeaways from Philips consent decree

Philips will have to undergo “an incredible undertaking” to meet requirements set out by the Food and Drug Administration in a consent decree last week,

April 17, 2024

New insights into serine hydroxymethyltransferase aid cancer drug design

In just two neutron experiments, scientists discovered remarkable details about the function of an enzyme that can aid drug design for aggressive cancers.

September 27, 2024

New approach to Parkinson’s treatment focuses on stopping toxic protein production

Like the Greek mythological beast with a snake’s tail and two ferocious heads, a potential Parkinson’s medicine created in the lab of chemist Matthew Disney,

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.